The South Yorkshire Integrated Medicines Optimisation Committee evaluates prescription products to determine the most appropriate care setting for their use in South Yorkshire and works collaboratively to develop treatment pathways across the South Yorkshire footprint.
- SY Integrated Medicines Optimisation Committee Meeting Minutes - 2 October 2024
- SY integrated Medicines Optimisation Committee Meeting Minutes - 3 July 2024
- SY integrated Medicines Optimisation Committee Meeting Minutes - 5 June 2024
- SY Integrated Medicines Optimisation Committee Meeting Minutes - 1 May 2024
- SY Integrated Medicines Optimisation Committee Meeting Minutes - 6 March 2024
- SY Integrated Medicines Optimisation Committee Meeting Minutes - 7 February 2024
- SY Integrated Medicines Optimisation Committee Meeting Minutes - 10 January 2024
- SY Integrated Medicines Optimisation Committee Meeting Minutes - 6 December 2023
SY Integrated Medicines Optimisation Committee Meeting Minutes - 7 December 2022
SY Integrated Medicines Optimisation Committee Meeting Minutes - 4 January 2023
SY Integrated Medicines Optimisation Committee Meeting Minutes - 1 February 2023
SY Integrated Medicines Optimisation Committee Meeting Minutes - 1 March 2023
SY Integrated Medicines Optimisation Committee Meeting Minutes - 5 April 2023
SY Integrated Medicines Optimisation Committee Meeting Minutes - 3 May 2023
SY Integrated Medicines Optimisation Committee Meeting Minutes - 7 June 2023
SY Integrated Medicines Optimisation Committee Meeting Minutes - 5 July 2023
SY Integrated Medicines Optimisation Committee Meeting Minutes - 6 September 2023
SY Integrated Medicines Optimisation Committee Meeting Minutes - 4 October 2023
SY Integrated Medicines Optimisation Committee Meeting Minutes - 1 November 2023
SY Integrated Medicines Optimisation Committee Meeting Minutes - 6 March 2024
Shared Care Protocol For Epilepsy in Adults
Shared Care Protocol For the Treatment of Parkinson’s disease
Shared Care protocol for Sublingual Immunotherapy (SLIT) (Grazax®/Acarizax®)
Shared Care Protocol For The Use of Efmody® in Patients with Adrenal Insufficiency (CAH)
Shared Care Protocol For Denosumab 60mg/mL injection (Prolia®)
Shared Care Protocol Use of Liothyronine (T3) for the treatment of hypothyroidism in selected cohort of adults despite optimal dosage with levothyroxine and where alternative cause of symptoms have been excluded.
Shared Care Protocol For Alimemazine in the treatment of sleep disorders in Children
Shared Care Protocol of Finerenone in patients with Chronic Kidney Disease and Type 2 Diabetes
This list is in development and is being led by the South Yorkshire IMOC. Currently it does not include medicines where Barnsley, Doncaster, Rotherham, Sheffield and Bassetlaw have previously agreed a placed based Traffic Light status. Harmonisation of placed based Traffic Light Drug List (TLDL) is underway with the long-term vision to have one TLDL for South Yorkshire.
NHS South Yorkshire Traffic Light Rationale and Criteria Document
Transfer of prescribing from private provider to NHS GP
South Yorkshire Self-Care Guidance
SYICB Position Statement on the prescribing of gabapentinoids
SY ICS Position statement Appropriate use of monitored Dosage Systems
South Yorkshire Valproate Guidance
Guidance for patients on HRT with unscheduled bleeding
Interim Position Statement: Hybrid Closed Loop (HCL) position statement